Manali Kamdar on Expanding access to CAR T-cell therapy outside academic centers
Manali Kamdar, MD, will present at 4:30–5 pm on January 20, 2026, on “Expanding access to CAR T-cell therapy outside.
The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.
Sharing clinical experience to support collective learning
Join SOHO Insider, the official media platform of the Society of Hematologic Oncology, for the inaugural Virtual Community Oncology Brown Bag Series, an informal lunchtime discussion program featuring community oncologists sharing real-world experiences from practice.
The program will be led and developed by Loretta J. Nastoupil, MD, our SOHO Insider Editorial leader in community oncology.
Registration is free and open to the public. All sessions are held on Zoom. Register at https://soho.click/community-oncology-series
Manali Kamdar, MD, will present at 4:30–5 pm on January 20, 2026, on “Expanding access to CAR T-cell therapy outside academic centers.”
Manali Kamdar, MD, will present at 4:30–5 pm on January 20, 2026, on “Expanding access to CAR T-cell therapy outside.
Live session held on February 11, 2026, from 2:00–2:30 PM CST with speaker Tara Graff presenting on "Implementing Bispecific Antibodies.
Held on March 18, 2026, from 12:30–1:00 PM CST with Jeffrey Matous presenting "Managing Access to Novel Agents in the.
Join the Community Oncology Brown Bag series "Addressing Workforce Shortages in Oncology" on April 2026 (date and time TBD).
Jeff Sharman, MD, Medical Director at US Oncology, will present "Exploration of Barriers and Solutions for Activating and Sustaining Research.
Join the Community Oncology Brown Bag Series for "Building Partnerships Between Community and Academic Centers" in July 2026 (date and.
Xavier Marin, MD, Hematologist, Scripps Clinic Medical Group, will present "Integrating New Evidence into Everyday Practice" on August 11, 2026.
Hans Lee, MD, Director of Myeloma Research at Sarah Cannon Research Institute presents "Increasing US Representation in Global Clinical Trials"
Shakira Grant, MBBS, MSCR, Founder and CEO of CROSS Global Research & Strategy, LLC, will present "AI Impacting Pathology and.
Dr. Nina Shah, Global Head of Multiple Myeloma Clinical Development and Strategy at AstraZeneca presents "How Can Pharma Engage with.